Recipharm
Recipharm acquires Mitim for £53.5m
Recipharm has acquired Mitim for £53.5m, adding scale and technology in injectable beta lactams to Recipharm’s portfolio, according to the company more »
Feb 29, 2016 4:54 PM News
Kr28 million for Pharmanest's IUD pain relief candidate
Recipharm Venture Fund, Östersjöstiftelsen and Praktikerinvest have jointly invested kr28 million in Pharmanest. Recipharm’s part of the investment is kr8 million. more »
Jul 9, 2015 11:14 AM News
OnTarget Chemistry acquisition broadens Recipharm's preclinical offering
Recipharm has bought OnTarget Chemistry, a CRO in Uppsala, Sweden, that specialises in medicinal chemistry, offering synthesis and analytical services that include rare and demanding specialties. more »
Jun 15, 2015 2:09 PM News
Recipharm partners with Follicum on drug development
Recipharm hassigned a partnership agreement with Follicum in preparation for a clinical trial of the drug candidate FOL-005. more »
Jun 2, 2015 8:44 AM News
Recipharm hires chief strategy officer
CDMO Recipharm has appointed Jean-François Hilaire to the new position of chief strategy officer, joining Recipharm’s group management team. more »
Jun 1, 2015 11:22 AM News
Recipharm appoints new General Manager
The contract development and manufacturing organisation, Recipharm, has announced that Giorgio Bruno has been appointed General Manager of Recipharm Italia S.p.A. more »
May 14, 2015 3:20 PM News
Recipharm and Adroit form solid pact
Recipharm and Adroit Science have formed a partnership in solid state characterisation services. more »
Mar 31, 2015 8:51 AM News
Recipharm acquires Lusomedicamenta for €50.7m
Recipharm has acquired Lisbon-based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A. more »
Nov 21, 2014 10:33 AM News
Recipharm forms new collaboration with Isofol Medical to exclusively manufacture Modufolin
At the same time, Recipharm Venture Fund has invested SEK 8 million in Isofol Medical. more »
Aug 27, 2014 11:55 AM
Recipharm to acquire Corvette Pharmaceutical Services Group for SEK 1.1 billion
The contract development and manufacturing organisation, Recipharm, has signed an agreement to acquire Milan-based Corvette Pharmaceutical Services Group from Italian private equity Group LBO Italia Investimenti. more »
Aug 20, 2014 9:58 AM
Recipharm and Pharmanest form collaboration for commercial manufacture and supply of SHACT
SHACT is a product based on an innovative formulation of lidocaine, a well-known anesthetic, and a proprietary application device developed to simplify topical application in the cervix and uterus. more »
Jul 3, 2014 2:02 PM News
Recipharm and CTC form collaboration
Double up: CTC Clinical Trial Consultants and Recipharm Pharmaceutical Development, have entered into a collaboration. more »
Jun 20, 2014 11:24 AM
Recipharm and CTC collaboration
Double up: CTC Clinical Trial Consultants and Recipharm Pharmaceutical Development, have entered into a collaboration. more »
Jun 20, 2014 11:24 AM News
Recipharm Presents Sixth International Environmental Award Winner
Recipharm has announced that its sixth International Environmental Award has been awarded to Ludwig Metz, Associate Director Environmental, Health & Safety, at pharmaceutical company Bristol–Myers Squibb. more »
Feb 7, 2014 3:33 PM Technology
Recipharm Enters German Market Collaboration for Development Services
Consulting and broker agency FHS Unternehmensberatung, based in Stuttgart, Germany, and CDMO Recipharm, based in Stockholm, Sweden, have entered into a collaboration. FHS Unternehmensberatung will sell and market Recipharm’s development services... more »
Oct 15, 2013 10:58 AM Technology
Recipham Expands Lyophilisation Capacity with €32 Million Investment in Germany
Recipharm has announced an investment of €32 million (£27.13 million) in its Wasserburg site located near Munich. The capital will be used to create a new building that will house a fourth production area, adding to the three already in operation. more »
Oct 9, 2013 5:29 PM Technology
Japan Approves Recipharm’s Manufacture of Cancer Pain Relief Tablet for Kyowa
Recipharm was informed on 20 September 2013 by the R&D-based pharmaceutical company Kyowa Hakko Kirin Co. Ltd. that the Abstral sublingual (under the tongue) tablet has been approved for manufacturing and marketing by Japan's Ministry of Health... more »
Sep 23, 2013 2:27 PM Technology
CDMO Provides Access to Salbutamol Inhaler Dossier for Chinese Market Approval
Recipharm is working with Vectura Group plc to provide the Chinese regulatory authorities with access to its licence for the regulatory dossier of Asmasal Clickhaler as part of the Chinese market approval process. The regulatory submission will... more »
Jun 21, 2013 3:03 PM Technology
Accurate Compressed Air Diagnosis Brings Healthy Savings for Pharma Manufacturer
Major European contract pharmaceuticals developer and manufacturer Recipharm recently called in Thorite engineers to carry out a data logging survey of compressed air production at the company’s UK facility in Ashton-under-Lyne. more »
May 31, 2013 10:00 AM Technology
Agreement to See CDMO’s Customers Benefit from Metal Coordination Chemistry
Recipharm Pharmaceutical Development and Synthonics have announced the formation of a joint promotion agreement. The contract, the first of its kind to be entered into between the two companies, will provide Recipharm customers with full access to... more »
May 16, 2013 5:01 PM Technology